13300-full
emackulate
Sex: F
Data Quality: 0 stars
MS: 4 yrs
Type: Relapsing-Remitting
Sensation: Moderate
Overall: Mild
Cognition: moderate
Vision: moderate
Speech: none
Swallowing: none
Upper limb: moderate
Walking: severe
emackulate
Female, 45 years
San Francisco, CA
Primary Condition
MS
Type
Relapsing-Remitting
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

emackulate's Rebif is for:

  • MS

emackulate's side effects of Rebif:

emackulate's Rebif History (Stopped)
Rebif (interferon beta-1a subq injection)
22 mcg/0.5 mL 3 times a week Aug 04 - Sep 07, 2009
44 mcg/0.5 mL 3 times a week Sep 07, 2009 - Sep 01, 2010
Stopped Did not seem to work and Doctor's advice Sep 01, 2010
Evaluations
Date Dosage MS (Multiple Sclerosis) Perceived effectiveness Side Effects Adherence Burden
Sep 01, 2010 44 mcg/0.5 mL 3 times a week ? NoneNoneNoneNone AlwaysAlwaysAlwaysAlways A littleA littleA littleA little
Sep 16, 2009 44 mcg/0.5 mL 3 times a week Led_efficacy_2Led_efficacy_2Led_defaultLed_default ModerateModerateModerateModerate AlwaysAlwaysAlwaysAlways A littleA littleA littleA little

About Rebif (Prescription Drug)

Rebif, a brand name for interferon beta-1a, is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It is given subcutaneously (under the skin) three times a week, ideally the same 3 days each week.

Learn more about Rebif in our Rebif Community Report.

Back to emackulate's Profile